medigraphic.com
ISSN 1405-8871 (Print)

2022, Number 2

<< Back Next >>

Aten Fam 2022; 29 (2)

Prevalence of Chronic Diseases in Patients Diagnosed with Intraepithelial Lesion of the Cervix

Garduño-Orbe B, Hernández-Wences B, Rayon-Castañeda CJ, García-Morales G

Language: Spanish
References: 33
Page: 97-102
PDF size: 133.24 Kb.


ABSTRACT

Objective: to identify the association between chronic diseases and intraepithelial lesion of the cervix in women between 25 and 60 years, in a Family Medicine Unit. Methods: cross-sectional analytical study, carried out from June to October 2020, through a simple random probability sampling. 533 women were included in the sample, from 25 to 60 years, with screening for cervical cancer by cervical cytology during 2019. Chronic disease was considered to be present when there was a record of personal pathological background in the clinical history OR medical note in the electronic medical record. The cervical cytology result was classified as normal, based on the Bethesda System, when there was no presence of HPV or cellular atypia; lowgrade lesion when there was presence of HPV and cervical intraepithelial neoplasia (CIN) 1; high-grade lesion with report of CIN 2, CIN 3 and cancer in situ. Descriptive statistics; bivariate analysis and logistic regression were performed to establish association with OR, 95% CI and p-value. Results: according to the cervical cytology report, it was normal in 69.8% (372/533), atypia in 3% (16/533), CIN 1 in 17.4% (93/533), CIN 2 in 5.6% (30/533), CIN 3 in 3.4% (18/533) and cancer in situ in 0.8% (4/533). The chronic conditions associated with intraepithelial lesions were bmi ≥30 with OR 1.3 and smoking or 3.3. Conclusion: in this investigation, three out of ten women presented intraepithelial lesion in the cervix. Smoking and obesity were identified as risk factors for squamous intraepithelial lesions of the cervix.


REFERENCES

  1. Organización Panamericana de la Salud. Enfermedades no transmisibles: hechos y cifras. OPS [Internet]. [Citado 2021 junio 22]. Disponible en: https://iris. paho.org/handle/10665.2/51482

  2. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-203.

  3. Bray F, Piñeros M. Patrones, tendencias y proyecciones del cáncer en América Latina y el Caribe: un contexto global. Salud Publica Mex. 2016;58:104-117.

  4. Pilleron S, Cabasag CJ, Ferlay J, Bray F, Luciani S, Almonte M, et al. Cervical cancer burden in Latin America and the Caribbean: Where are we? Int J Cancer. 2020;147(6):1638-1648.

  5. Solís JG, Briones-Torres TI. Prevalencia de lesión intraepitelial en citología cervical de tamizaje en una unidad de primer nivel de atención. Rev Med Inst Mex Seguro Soc. 2018;56(2):167-172.

  6. Sánchez-Mercader A, Cámara-Salazar A, Traconis- Díaz V, Sánchez-Buenfil G. Análisis de la mortalidad por cáncer cervicouterino en México y el Estado de Yucatán. Ginecol Obstet Mex. 2021;89(9):671-677.

  7. Velazquez C, Kawabata A, Rios-González CM. Prevalencia de lesiones precursoras de cáncer de cuello uterino y antecedentes sexuales/ reproductivos de indígenas de Caaguazú, Paraguay 2015-2017. Rev. Salud Publica Parag. 2018;8(2):15-20.

  8. Nygård M, Hansen BT, Kjaer SK, Hortlund M, Tryggvadóttir L, Munk C, et al. Human papillomavirus genotype-specific risks for cervical intraepithelial lesions. Hum Vaccin Immunother. 2021;17(4):972-981.

  9. Orumaa M, Leinonen MK, Campbell S, Moller B, Myklebust TA, Nygård M. Recent increase in incidence of cervical precancerous lesions in Norway: nationwide study from 1992 to 2016. Int J Cancer. 2019;145:2629-2638.

  10. Nayar R, Wilbur DC. The Bethesda System for Reporting Cervical Cytology: A Historical Perspective. Acta Cytol. 2017;61(4-5):359-372.

  11. Kaplan S. Risk Factors that Cause Cervical Intraepithelial Lesion Development: A Single Center Crosssectional Study in Turkey. Asian Pac J Cancer Care. 2020;5(3):173-178.

  12. Lee DY, Lee TS. Associations between metabolic syndrome and gynecologic cancer. Obstet Gynecol Sci. 2020;63(3):215-224.

  13. Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki OU, et al. Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer. J Clin Oncol 2018.36(12):1184-1191.

  14. Nagaraju GP, Rajitha B, Aliya S, Kotipatruni RP, Madanraj AS, Hammond A, et al. The role of adiponectin in obesity associated female specific carcinogénesis. Cytokine Growth Factor Rev. 2016;31:37-48.

  15. Gelsomino L, Naimo GD, Catalano S, Mauro L, Andó S. The emerging role of adiponectin in female malignancies. Int J Mol Sci. 2019;20(9):2127.

  16. Abudawood M. Diabetes and cancer: A comprehensive review. J Res Med Sci. 2019;24:94-100.

  17. Yang WS, Chen PC, Lin, HJ, Su TC, Hsu HC, Chen MF, et al. Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study. Acta Diabetol. 2017;54(5):455-461.

  18. Chen S, Tao M, Zhao L, Zhang X. The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(40):7981-7987.

  19. Lam C, Cronin K, Ballard R, Mariotto A. Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER-Medicare-linked data resource. Cancer Med. 2018;7(7):3434-44.

  20. Hernández-Garduño E. The association between diabetes and cancer in Mexico: Analysis using death certificate databases, 2009-2017. J Can Res Ther. 2021;20:1-7.

  21. González-Svatetz CA, Goday-Arnó A. Obesidad y cáncer: «las amistades peligrosas». Med Clin (Barc). 2015;145(1):24-30.

  22. Sánchez-Hernández JA, García-Amaya CV, Muñoz- Zurita G. Tabaquismo y atipias celulares cérvicovaginales. Aten Fam. 2017;24(1):3-7.

  23. Cabrera-Guerra II, Ortiz-Sánchez Y, Suárez-Gómez YL, Socarrás-Rodríguez R, Vázquez-Rosales N. Factores de riesgo asociados al cáncer de cuello uterino en el área de salud de Santa Rita. Mul Med. 2016;20(5):110-128.

  24. Nagelhout G, Ebisch RM, Van Der Hel O, Meerkert GJ, Magnée T, De Bruijn T, et al. Is smoking an independent risk factor for developing cervical intraepithelial neoplasia and cervical cancer? A systematic review and meta-analysis. Expert Rev Anticancer Ther. 2021;21(7):781-794.

  25. Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, Smaill F, et al. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis. 2013;208(3):454-62.

  26. Ahn S, Kim GJ, Do SI, Kim K, Lee H, Do IG, et al. High-sensitivity C-reactive Protein and Regression of Low-grade Squamous Intraepithelial Lesion: The Role of Low-grade Inflammation in Cervical Carcinogenesis. J Epidemiol. 2021;31(12):615-620.

  27. El-Moselhy EA, Borg HM, Atlam SA. Cervical Cancer: Sociodemographic and Clinical Risk Factors among Adult Egyptian Females. Adv Oncol Res Treat. 2016;1(1):106.

  28. Al-Madani W, Ahmed AE, Arabi H, Al Khodairy S, Al Mutairi N, Jazieh AR. Modelling risk assessment for cervical cancer in symptomatic Saudi women. Saudi Med J. 2019;40(5):447-451.

  29. Sugawara Y, Tsuji I, Mizoue T, Inoue M, Sawada N, Matsuo K, et al. Cigarette smoking and cervical cancer risk: an evaluation based on a systematic review and meta-analysis among Japanese women. Jpn J Clin Oncol. 2019;49(1):77-86.

  30. Plummer M, Herrero R, Franceschi S, Meijer C, Snijders P, Bosch F et al. Smoking and cervical cáncer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control. 2003;14(9):805‐814.

  31. Grabar S, Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, et al. Invasive cervical cancer in HIVinfected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) CO4 cohort study. HIV Medicine. 2019;20:222-229.

  32. Chambuso RS, Shadrack S, Lidenge SJ, Mwakibete N, Medeiros RM. Influence of HIV/AIDS on Cervical Cancer: A Retrospective Study From Tanzania. J Glob Oncol. 2016;3(1):72-78.

  33. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283:1031-1037. Garduño-Orbe B y cols. Aten Fam. 2022;29(2):97-102. http://dx.doi.org/10.22201/fm.14058871p.2022.2.82032




2020     |     www.medigraphic.com